Cencora stock at EUR 289.50 with USD 63.1 billion market value

Published on 10/09/2026 at 20:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora stock was at EUR 289.50 on October 9, 2026, plus 0.99 percent versus EUR 286.65. Market value was USD 63.1 billion and P/E was 24.08.

Key points in brief

Cencora stock was EUR 289.50 at Lang & Schwarz on October 9, 2026, with a 0.99 percent change versus the prior close.
The company had a USD 63.1 billion market capitalization and a P/E ratio of 24.08.
Trading volume was 321,889 shares versus an average volume of 1,321,853 shares.
Cencora plans to report fourth-quarter fiscal 2026 results on November 4, 2026.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora stock was trading at EUR 289.50 at Lang & Schwarz on October 9, 2026 at 8:32 p.m. CEST, with a 0.99 percent change versus the prior close of EUR 286.65. The quote was in the after-hours phase for German investors, while Cencora's primary listing is on the New York Stock Exchange.

Trading range and volume

On the NYSE, Cencora was last at USD 324.29 on October 9, 2026 at 2:33 p.m. ET. Its 52-week range was USD 244.82 to USD 377.54, placing the US price below the period high while keeping the stock well above its low.

Trading volume stood at 321,889 shares on October 9, 2026, compared with an average volume of 1,321,853 shares. That is a minus 75.65 percent difference against the average, so the session's turnover was materially lighter than the recent norm.

Valuation and calendar

Cencora's market capitalization was USD 63.1 billion on October 9, 2026, and its price-to-earnings ratio was 24.08. The valuation figures describe the US-listed security and are separate from the euro quote at Lang & Schwarz.

According to Cencora on October 2, 2026, the company plans to release fourth-quarter fiscal 2026 results on November 4, 2026, before trading opens on the New York Stock Exchange. The conference call is scheduled for 8:30 a.m. ET that day.

Comparison with peers

Cencora Inc.: plus 0.99 percent, P/E 24.08, market capitalization USD 63.1 billion
Cardinal Health (NYSE, USD): minus 0.38 percent, P/E 32.92, market capitalization USD 55.8 billion
McKesson Corporation (NYSE, USD): plus 1.18 percent, P/E 25.19, market capitalization USD 110.2 billion

EUR 289.50 in after-hours trading

The Lang & Schwarz quote stood at EUR 289.50 on October 9, 2026 at 8:32 p.m. CEST, with a 0.99 percent change versus the EUR 286.65 prior close from October 8, 2026. For German investors, the next scheduled company event is the November 4, 2026 fiscal fourth-quarter report.

The further course of trading is shown by the continuously updated real-time quote of Cencora stock.